Unknown

Dataset Information

0

Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients.


ABSTRACT: BACKGROUND: The enzymes of the cytochrome P450 family (CYPs) play an important role in the metabolism of a great variety of anticancer agents; therefore, polymorphisms in genes encoding for metabolizing enzymes and drugs transporters can affect drug efficacy and toxicity. METHODS: The genetic polymorphisms of cytochrome P450 were studied in 395 patients with breast cancer by RLFP analysis. RESULTS: Here, we studied the association of functionally significant variant alleles of CYP3A4, CYP3A5, CYP2B6, CYP2C8, CYP2C9 and CYP2C19 with the clinical response to neoadjuvant chemotherapy in breast cancer patients. A significant correlation was observed between the CYP2C9*2 polymorphism and chemotherapy resistance (OR = 4.64; CI 95% = 1.01 - 20.91), as well as between CYP2C9*2 heterozygotes and chemotherapy resistance in women with nodal forms of breast cancer and a cancer hereditary load (OR = 15.50; CI 95% = 1.08 - 826.12) when the potential combined effects were examined. No significant association between chemotherapy resistance and the other examined genotypes and the potential combined clinical and tumour-related parameters were discovered. CONCLUSION: In conclusion, CYP2C9*2 was associated with neoadjuvant chemotherapy resistance (OR = 4.64; CI 95% = 1.01 - 20.91) in the population of interest.

SUBMITTER: Seredina TA 

PROVIDER: S-EPMC3458973 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients.

Seredina Tatyana A TA   Goreva Olga B OB   Talaban Valeria O VO   Grishanova Alevtina Yu AY   Lyakhovich Vyacheslav V VV  

BMC medical genetics 20120615


<h4>Background</h4>The enzymes of the cytochrome P450 family (CYPs) play an important role in the metabolism of a great variety of anticancer agents; therefore, polymorphisms in genes encoding for metabolizing enzymes and drugs transporters can affect drug efficacy and toxicity.<h4>Methods</h4>The genetic polymorphisms of cytochrome P450 were studied in 395 patients with breast cancer by RLFP analysis.<h4>Results</h4>Here, we studied the association of functionally significant variant alleles of  ...[more]

Similar Datasets

| S-EPMC6727505 | biostudies-literature
| S-EPMC10612355 | biostudies-literature
| S-EPMC3438554 | biostudies-literature
| S-EPMC5608188 | biostudies-literature
| S-EPMC7851625 | biostudies-literature
| S-EPMC8062093 | biostudies-literature
| PRJEB38781 | ENA
| S-EPMC4123826 | biostudies-literature
| S-EPMC5888975 | biostudies-literature
| S-EPMC6747359 | biostudies-literature